Actively Recruiting
Evaluation of the Quality of Life of Patients With DBB With the Installation of OPEP
Led by Centre Hospitalier Universitaire, Amiens · Updated on 2026-01-23
60
Participants Needed
1
Research Sites
75 weeks
Total Duration
On this page
Sponsors
C
Centre Hospitalier Universitaire, Amiens
Lead Sponsor
H
Hôpital Armand Trousseau
Collaborating Sponsor
AI-Summary
What this Trial Is About
To carry out an assessment of compliance and quality of life in a population (children and adults) with DDB before and after the use of an oscillating PEP. The aim is to determine the impact of the use of oscillating PEP on the daily life of this population in particular.
CONDITIONS
Official Title
Evaluation of the Quality of Life of Patients With DBB With the Installation of OPEP
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children aged 8 years and older and adults over 18 years with bronchiectasis (DDB) not currently using oscillating PEP
- Clinically stable patients
- Patients attending regular follow-up consultations
You will not qualify if you...
- Children under 8 years of age
- Patients currently using an oscillating PEP device
- Patients experiencing an acute exacerbation of bronchiectasis
- Patients not under regular medical consultation
- Patients with severe, uncontrolled co-morbidities
- Patients with cognitive or psychiatric disorders that interfere with study adherence
- Patients participating in another clinical study that could affect results
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Amiens-Picardie
Amiens, France, 80054
Actively Recruiting
Research Team
T
Thomas PINTO, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here